Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Mammoth Biosciences

Main focus: Diagnostics and treatment of genetic diseases using novel Cas enzymes

Company stage: Commercial (diagnostics), pre-clinical (therapeutics)

Diseases: COVID-19 (diagnostic), otherwise undisclosed

Genome editing tool: Cas14 and CasΦ

Funding stage: Private

Location: Brisbane CA, USA

Website: https://mammoth.bio/

Partners: Vertex Pharmaceuticals, Merck, GlaxoSmithKline

Mammoth Biosciences is focused on discovering novel CRISPR systems for diagnostics and therapeutic applications. The company is currently developing CRISPR-Cas12, Cas13, Cas14 and CasΦ, which may provide advantages over currently used systems. The DETECTRTM platform is based on these CRISPR systems, and has so far been applied out for SARS-CoV-2 testing. Although the lead programmes remain undisclosed, the company also develops its CRISPR systems for the treatment of genetic diseases. The company is co-founded by Nobel Laureate, Jennifer Doudna.

Tags

HashtagMammoth Biosciences, Inc.

Company: Mammoth Biosciences
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine